Sandbox Reserved 1103

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 27: Line 27:
=== Dyskeratosis congenita ===
=== Dyskeratosis congenita ===
-
The unifying features Dyskeratosis congenita (DC) is a disorder which is characterised by bone marrow dysfunction, abnormality of the skin, mucocutaneous triad of oral leucoplakia, nail dystrophy, as well as a predisposition to cancer.
+
Dyskeratosis congenita (DC) is a disorder which is characterised by bone marrow dysfunction, abnormality of the skin, mucocutaneous triad of oral leucoplakia, nail dystrophy, as well as a predisposition to cancer.
-
TIN2 is one of the nine identified genes that when mutated are related to the Dyskeratosis congenita, the others being DKC1, TERC, TERT, NOP10, NHP2, TIN2, C16orf57, TCAB1 and PARN.
+
TINF2 is one of the nine identified genes that when mutated are related to the Dyskeratosis congenita, the others being DKC1, TERC, TERT, NOP10, NHP2, TIN2, C16orf57, TCAB1 and PARN.
-
The mutated region of TIN2 in Dyskeratosis congenita patients is situated near the ends of its TRF1 binding domain. The majority of identified TIN2-DC mutations cluster is a highly conserved 30-amino-acid region from position 270 to 300, located eight amino acids C-terminal to the FxLxP motif that mediates binding of TIN2 to TRF1 <ref>PMID: 18252230 </ref>. Another proposal is that TIN2 help TPP1, another component of the shelterin complex, in the recruitment of telomerase through an unknown mechanism that is disrupted by the TIN2-DC mutations, including K280E <ref>PMID: 18202258 </ref> <ref>PMID: 18252230 </ref>.
+
The majority of identified TIN2-DC mutations cluster is a highly conserved 30-amino-acid region near the ends of its TRF1 binding domain, from position 270 to 300, located eight amino acids C-terminal to the FxLxP motif. A disrutpion of this domain causes a loss of TRF1 binding to TIN2;<ref>PMID: 18252230 </ref>. Another proposal is that TIN2 help TPP1, another component of the shelterin complex, in the recruitment of telomerase through an unknown mechanism that is disrupted by the TIN2-DC mutations, including K280E <ref>PMID: 18202258 </ref> <ref>PMID: 18252230 </ref>.
=== Revesz syndrome ===
=== Revesz syndrome ===
 +
Revesz syndrome is characterised by bone marrow <ref>PMID: 17901676 </ref>. Revesz syndrome is according to some researcher to be part of the DKC disease spectrum. Patients with Revesz syndrome have presented with heterozygous mutations in TINF2 gene which is located on chromosome 14q12. There is no treatment for this disease yet.
Revesz syndrome is characterised by bone marrow <ref>PMID: 17901676 </ref>. Revesz syndrome is according to some researcher to be part of the DKC disease spectrum. Patients with Revesz syndrome have presented with heterozygous mutations in TINF2 gene which is located on chromosome 14q12. There is no treatment for this disease yet.

Revision as of 19:37, 16 January 2020

TRF1 TRFH domain and TIN2 peptide complex, pdb=3BQO

The TRFH (Telomeric Repeat Factor Homology) is a domain which is in the centre of the TRF1(Telomeric Repeat-Binding Factor) and of about 200 amino acids.In humans TERF1 is encoded by the TERF1 gene. TIN2(TERF1-interacting Nuclear Factor) is a protein encoded in humans by the TINF2 gene that can bind to TRFH TRF1.

Drag the structure with the mouse to rotate
Personal tools